 Following the acquisition, the company restructured its executive leadership, with Paul Bisaro being named Executive Chairman, and Brent Saunders being appointed CEO and President of the combined organization.In November 2014, Actavis PLC announced its intention to acquire Allergan Inc, the manufacturer of Botox Completion of the deal would increase its market capitalization to $147 billion.On March 17, 2015, Actavis PLC completed the acquisition of Allergan Inc in a cash and equity transaction valued at approximately $70.5 billion.